Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $735,841 | 374 | 81.7% |
| Travel and Lodging | $62,137 | 129 | 6.9% |
| Consulting Fee | $52,134 | 25 | 5.8% |
| Food and Beverage | $39,953 | 1,510 | 4.4% |
| Honoraria | $9,928 | 7 | 1.1% |
| Education | $1,058 | 22 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $244,312 | 309 | $0 (2024) |
| PFIZER INC. | $124,798 | 205 | $0 (2024) |
| Celgene Corporation | $101,224 | 101 | $0 (2019) |
| Dermavant Sciences, Inc. | $89,268 | 70 | $0 (2024) |
| GENZYME CORPORATION | $85,774 | 97 | $0 (2024) |
| ABBVIE INC. | $66,226 | 261 | $0 (2024) |
| Amgen Inc. | $65,330 | 114 | $0 (2024) |
| Galderma Laboratories, L.P. | $48,634 | 120 | $0 (2024) |
| LEO Pharma Inc. | $36,014 | 145 | $0 (2024) |
| Promius Pharma LLC | $16,222 | 127 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $152,774 | 298 | GENZYME CORPORATION ($57,312) |
| 2023 | $144,304 | 249 | Dermavant Sciences, Inc. ($50,846) |
| 2022 | $90,474 | 191 | Lilly USA, LLC ($35,879) |
| 2021 | $66,049 | 198 | Lilly USA, LLC ($28,144) |
| 2020 | $60,692 | 159 | Lilly USA, LLC ($40,650) |
| 2019 | $172,173 | 385 | Lilly USA, LLC ($83,492) |
| 2018 | $136,952 | 337 | Galderma Laboratories, L.P. ($37,966) |
| 2017 | $77,633 | 250 | Celgene Corporation ($35,825) |
All Payment Transactions
2,067 individual payment records from CMS Open Payments — Page 1 of 83
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Immunology | ||||||
| 12/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.87 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $87.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,674.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.99 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $77.80 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 915 | 1,439 | $299,139 | $84,884 |
| 2022 | 12 | 924 | 1,266 | $255,598 | $81,982 |
| 2021 | 14 | 1,083 | 1,664 | $305,084 | $86,093 |
| 2020 | 13 | 837 | 1,447 | $127,057 | $54,298 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 349 | 549 | $136,800 | $37,269 | 27.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 154 | 195 | $37,146 | $9,436 | 25.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $29,385 | $8,616 | 29.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 31 | 32 | $22,452 | $8,091 | 36.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 80 | 100 | $24,530 | $7,884 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 45 | $13,500 | $4,603 | 34.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 22 | 24 | $14,736 | $2,912 | 19.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 30 | 31 | $8,300 | $2,694 | 32.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 91 | 320 | $7,040 | $1,839 | 26.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 19 | 35 | $5,250 | $1,542 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 317 | 498 | $99,600 | $33,877 | 34.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 129 | 129 | $30,057 | $9,774 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 149 | 192 | $34,944 | $8,355 | 23.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 82 | 102 | $22,440 | $7,665 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 55 | $16,500 | $5,523 | 33.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 17 | 19 | $12,939 | $4,931 | 38.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 39 | 41 | $10,250 | $3,677 | 35.9% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2022 | 14 | 16 | $6,720 | $2,728 | 40.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2022 | 12 | 13 | $7,982 | $1,591 | 19.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 24 | 36 | $5,400 | $1,530 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,400 | $1,512 | 28.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 91 | 153 | $3,366 | $819.32 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 272 | 404 | $79,205 | $27,434 | 34.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 146 | 146 | $39,363 | $13,068 | 33.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 119 | 142 | $46,875 | $11,799 | 25.2% |
About Marcus Mcferren, MD, PHD
Marcus Mcferren, MD, PHD is a Dermatology healthcare provider based in Orange, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1891971651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marcus Mcferren, MD, PHD has received a total of $901,052 in payments from pharmaceutical and medical device companies, with $152,774 received in 2024. These payments were reported across 2,067 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($735,841).
As a Medicare-enrolled provider, Mcferren has provided services to 3,759 Medicare beneficiaries, totaling 5,816 services with total Medicare billing of $307,257. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Orange, CT
- Active Since 01/11/2008
- Last Updated 04/11/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1891971651
Products in Payments
- TALTZ (Drug) $190,485
- Otezla (Drug) $165,871
- VTAMA (Drug) $89,268
- DUPIXENT (Biological) $86,742
- EUCRISA (Drug) $78,693
- SKYRIZI (Biological) $35,013
- EPIDUO FORTE (Drug) $29,338
- OLUMIANT (Drug) $28,764
- PICATO (Drug) $21,867
- Olumiant (Drug) $19,100
- CIBINQO (Drug) $17,353
- ENSTILAR (Drug) $13,542
- ORACEA (Drug) $12,920
- LITFULO (Drug) $11,154
- Humira (Biological) $10,032
- Trianex (Drug) $9,778
- RINVOQ (Biological) $6,896
- QBREXZA (Drug) $6,435
- SOOLANTRA (Drug) $6,013
- HUMIRA (Biological) $5,680
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Orange
Anand Ganesan, Md, MD
Dermatology — Payments: $24,687
Karol Dangaran, M.d, M.D
Dermatology — Payments: $13,215
Dr. Amandeep Sandhu, M.d, M.D
Dermatology — Payments: $13,035
Mary Jung, M.d, M.D
Dermatology — Payments: $10,691
Khasha Touloei, Do, DO
Dermatology — Payments: $8,954
Jessica Hsu, M.d, M.D
Dermatology — Payments: $7,026